Anixa Biosciences Market Cap

Anixa Biosciences has a market cap or net worth of $101.46 million as of July 11, 2025. Its market cap has increased by 26.83% in one year.

Market Cap

101.46M

Enterprise Value

85.77M

1-Year Change

26.83%

Ranking

#4145

Market Cap Chart

Since December 1, 1998, Anixa Biosciences's market cap has increased from $83.20M to $101.46M, an increase of 21.95%. That is a compound annual growth rate of 0.75%.

Market Cap History

Date	Market Cap	% Change
Jul 10, 2025	101.10M	35.34%
Dec 31, 2024	74.70M	-38.06%
Dec 29, 2023	120.60M	-7.44%
Dec 30, 2022	130.30M	46.40%
Dec 31, 2021	89.00M	21.92%
Dec 31, 2020	73.00M	10.11%
Dec 31, 2019	66.30M	-10.04%
Dec 31, 2018	73.70M	106.44%
Dec 29, 2017	35.70M	-24.52%
Dec 30, 2016	47.30M	79.85%
Dec 31, 2015	26.30M	10.04%
Dec 31, 2014	23.90M	-39.34%
Dec 31, 2013	39.40M	18.32%
Dec 31, 2012	33.30M	73.44%
Dec 30, 2011	19.20M	-39.81%
Dec 31, 2010	31.90M	-65.14%
Dec 31, 2009	91.50M	61.95%
Dec 31, 2008	56.50M	-63.00%
Dec 31, 2007	152.70M	62.27%
Dec 29, 2006	94.10M	31.24%
Dec 30, 2005	71.70M	-0.42%
Dec 31, 2004	72.00M	94.07%
Dec 31, 2003	37.10M	183.21%
Dec 31, 2002	13.10M	-52.88%
Dec 31, 2001	27.80M	-35.94%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	709.79B
Johnson & Johnson	379.41B
AbbVie	344.45B
Novo Nordisk	316.64B
UnitedHealth Group	271.70B
Novartis AG	243.81B
Abbott Laboratories	232.44B
AstraZeneca	223.49B

Market Cap Rankings